Guosheng Wu1, Qingchuan Zhao2, Xiaohua Li2, Mian Wang2, Hao Sun2, Jingson Zhang3, Zengshan Li4, Jianyong Zheng2, Mengbin Li2, Daiming Fan2. 1. State Key Laboratory of Cancer Biology & National Clinical Research Center for Digestive Diseases, Xijing Hospital, The Fourth Military Medical University, 127 Changle West Rd, Xi'an, Shannxi, 710032, People's Republic of China. guosheng_w@yahoo.com. 2. State Key Laboratory of Cancer Biology & National Clinical Research Center for Digestive Diseases, Xijing Hospital, The Fourth Military Medical University, 127 Changle West Rd, Xi'an, Shannxi, 710032, People's Republic of China. 3. Department of Radiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China. 4. Department of Pathology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Abstract
BACKGROUND: Intestinal autotransplantation (IATx) is a novel surgical technique for neoplasms arising from the pancreas, duodenum, mesentery, or retroperitoneum with involvement of the superior mesenteric artery (SMA). The value of this aggressive procedure remains to be defined. We describe its surgical indications, postoperative complications, and clinical outcomes after IATx. METHODS: Fifteen patients aged 20 to 67 years (mean 44.9 years) underwent IATx in our program from January 2011 to January 2018. In all patients, selection and harvesting of a healthy bowel autograft were initially carried out, and an extended en bloc resection of neoplasms was performed afterward. RESULTS: Of the 15 patients, there was one early death from a pancreatic leak and two late deaths either from disease recurrence or sudden cardiac arrest. Ten patients developed 23 postoperative complications. Of these, one patient lost his bowel autograft due to arterial thrombosis 48 h later. Delayed gastric emptying, pleural effusions, pancreatic fistula, and relaparotomy were the most common complications. In our series, four of nine patients with invasive malignant neoplasms had evidence of disease recurrence at 13, 13, 16, and 18 months after IATx. At a median follow-up of 29.9 months, 11 patients undergoing successful IATx remained alive with a well-functioning bowel graft. CONCLUSION: Our results indicate that IATx is technically feasible with acceptable perioperative morbidity and mortality. This procedure should be considered in selected patients presenting with locally invasive neoplasms involving the SMA.
BACKGROUND: Intestinal autotransplantation (IATx) is a novel surgical technique for neoplasms arising from the pancreas, duodenum, mesentery, or retroperitoneum with involvement of the superior mesenteric artery (SMA). The value of this aggressive procedure remains to be defined. We describe its surgical indications, postoperative complications, and clinical outcomes after IATx. METHODS: Fifteen patients aged 20 to 67 years (mean 44.9 years) underwent IATx in our program from January 2011 to January 2018. In all patients, selection and harvesting of a healthy bowel autograft were initially carried out, and an extended en bloc resection of neoplasms was performed afterward. RESULTS: Of the 15 patients, there was one early death from a pancreatic leak and two late deaths either from disease recurrence or sudden cardiac arrest. Ten patients developed 23 postoperative complications. Of these, one patient lost his bowel autograft due to arterial thrombosis 48 h later. Delayed gastric emptying, pleural effusions, pancreatic fistula, and relaparotomy were the most common complications. In our series, four of nine patients with invasive malignant neoplasms had evidence of disease recurrence at 13, 13, 16, and 18 months after IATx. At a median follow-up of 29.9 months, 11 patients undergoing successful IATx remained alive with a well-functioning bowel graft. CONCLUSION: Our results indicate that IATx is technically feasible with acceptable perioperative morbidity and mortality. This procedure should be considered in selected patients presenting with locally invasive neoplasms involving the SMA.
Entities:
Keywords:
Clinical outcomes; Intestinal autotransplantation; Neoplasms; SMA resection
Authors: Ivo G Tzvetanov; Chandra S Bhati; Hoonbae Jeon; Andrew E Glover; Jose Oberholzer; Enrico Benedetti Journal: Surgery Date: 2011-10-06 Impact factor: 3.982
Authors: T Kato; S J Lobritto; A Tzakis; Y Raveh; P R Sandoval; M Martinez; L Granowetter; A Armas; R S Brown; J Emond Journal: Am J Transplant Date: 2012-02-02 Impact factor: 8.086
Authors: Nathan Mollberg; Nuh N Rahbari; Moritz Koch; Werner Hartwig; Yumiko Hoeger; Markus W Büchler; Jürgen Weitz Journal: Ann Surg Date: 2011-12 Impact factor: 12.969
Authors: Claudio Bassi; Christos Dervenis; Giovanni Butturini; Abe Fingerhut; Charles Yeo; Jakob Izbicki; John Neoptolemos; Michael Sarr; William Traverso; Marcus Buchler Journal: Surgery Date: 2005-07 Impact factor: 3.982
Authors: J J Xiong; C L Tan; P Szatmary; W Huang; N W Ke; W M Hu; Q M Nunes; R Sutton; X B Liu Journal: Br J Surg Date: 2014-07-16 Impact factor: 6.939
Authors: Kathleen K Christians; Charles H C Pilgrim; Susan Tsai; Paul Ritch; Ben George; Beth Erickson; Parag Tolat; Douglas B Evans Journal: Surgery Date: 2014-01-22 Impact factor: 3.982
Authors: Moritz N Wente; Johannes A Veit; Claudio Bassi; Christos Dervenis; Abe Fingerhut; Dirk J Gouma; Jakob R Izbicki; John P Neoptolemos; Robert T Padbury; Michael G Sarr; Charles J Yeo; Markus W Büchler Journal: Surgery Date: 2007-07 Impact factor: 3.982